SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000912057-01-509193
Filing Date
2001-04-17
Accepted
2001-04-17 00:00:00
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a2045339zsc13da.txt SC 13D/A 11887
2 INFORMATION CONCERNING EXECUTIVE OFFICERS & DIRS. a2045339zex-1.txt EX-1 10488
3 WAIVER OF CONTRACTUAL RESTRICTIONS a2045339zex-2.txt EX-2 5941
  Complete submission text file 0000912057-01-509193.txt   30510
Mailing Address
Business Address 100 ABBOTT PARK ROAD D-322 AP6D ABBOTT PARK IL 60064-3500 8479376100
ABBOTT LABORATORIES (Filed by) CIK: 0000001800 (see all company filings)

IRS No.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 6194526600
LA JOLLA PHARMACEUTICAL CO (Subject) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-44849 | Film No.: 1604667
SIC: 2836 Biological Products, (No Diagnostic Substances)